RANDOMIZED CONTROLLED TRIAL OF ADJUNCTIVE ROSUVASTATIN FOR TUBERCULOSIS TREATMENT
In vitro and animal model data suggest statins may have benefit as adjunctive host-directed therapy for tuberculosis. Rosuvastatin has minimal interaction with rifampicin and is available in generic formulation. We hypothesised that rosuvastatin, at standard treatment doses used for lipid reduction, might accelerate sputum culture conversion. We randomised patients with rifampicin-susceptible TB (smear ?1 positive…